[1]刘青, 张蕾, 张利元, 等. Circ_0038467靶向miR-182调控肺炎链球菌(Sp)诱导的人肺泡上皮细胞系HPAEpiC损伤[J]. 基础医学与临床, 2021, 41:1277-1284. [2]McMahan RH, Hulsebus HJ, Najarro KM, et al. Age-related intestinal dysbiosis and enrichment of gut-specific bacteria in the lung are associated with increased susceptibility to Streptococcus pneumoniae infection in mice[J]. Front Aging, 2022, 3:859991-859999. [3]Kosutova P, Mikolka P, Kolomaznik M, et al. Reduction of lung inflammation, oxidative stress and apoptosis by the PDE4 inhibitor roflumilast in experimental model of acute lung injury[J]. Physiol Res, 2018, 67:S645-S654. [4]Peng CK, Huang KL, Wu CP, et al. Phosphodiesterase-4 inhibitor roflumilast attenuates pulmonary air emboli-induced lung injury[J]. J Surg Res, 2019, 241:24-30. [5]Chen IC, Wang SC, Chen YT, et al. Corylin ameliorates LPS-induced acute lung injury via suppressing the MAPKs and IL-6/STAT3 signaling pathways[J]. Pharmaceuticals (Basel), 2021, 14:1046-1058. [6]王艺颖, 简鼎, 朱琳, 等. Notch1在新生期小鼠肺炎链球菌感染诱导Th1/Th2失衡[J]. 陆军军医大学学报, 2022, 44:2138-2145. [7]Kosutova P, Mikolka P, Kolomaznik M, et al. Reduction of lung inflammation, oxidative stress and apoptosis by the PDE4 inhibitor roflumilast in experimental model of acute lung injury[J]. Physiol Res, 2018, 67:S645-S654. [8]Wang X, Yang B, Li Y, et al. AKR1C1 alleviates LPS induced ALI in mice by activating the JAK2/STAT3 signaling pathway[J]. Mol Med Rep, 2021, 24:833-845. [9]Yang Y, Huang L, Tian C, et al. Magnesium isoglycyrrhizinate inhibits airway inflammation in rats with chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2021, 21:371-379. [10]Clark SE, Schmidt RL, Aguilera ER, et al. IL-10-producing NK cells exacerbate sublethal Streptococcus pneumo-niae infection in the lung[J]. Transl Res, 2020, 226:70-82. [11]Chen Z, Zheng B, Zhang Z, et al. Protective role of FBXL19 in Streptococcus pneumoniae-induced lung injury in pneumonia immature mice[J]. J Cardiothorac Surg, 2023, 18:92-103. [12]Zhang Z, Liang M, Wan X. Roflumilast, a type of phosphodiesterase 4 inhibitor, can reduce intestinal injury caused by sepsis[J]. Exp Ther Med, 2021, 22:1398-1409. [13]Cao HY, Yu TH, Han CH, et al. Roflumilast, a phosphodiesterase-4 inhibitor, improves hyperoxia-induced lung injury via anti-inflammation[J]. Undersea Hyperb Med, 2020, 47:189-196. [14]Kamel MY, Ahmed SM, Abdelzaher WY, et al. Role of IL-6/STAT3 pathway in mediating the protective effect of agomelatine against methotrexate-induced lung/intestinal tissues damage in rats[J]. Immunopharmacol Immunotoxicol, 2022, 44:35-46. [15]Huo S, Shi W, Ma H, et al. Alleviation of inflammation and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via IL-6/STAT3 inhibition by raloxifene[J]. Oxid Med Cell Longev, 2021, 2021:6699054-6699065. |